850462-65-6

Basic information

• Product Name: Benzoic acid,2-(broMoMethyl)-5-fluoro-3-nitro-, Methyl ester
• Synonyms: Benzoic acid,2-(broMoMethyl)-5-fluoro-3-nitro-, Methyl ester;methyl 2-(bromomethyl)-5-fluoro-3-nitrobenzoate
• CAS NO: 850462-65-6
• Molecular Formula: C₉H₇BrFNO₄
• Molecular Weight: 292.0585832
• Mol File: 850462-65-6.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Benzoic acid,2-(broMoMethyl)-5-fluoro-3-nitro-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid,2-(broMoMethyl)-5-fluoro-3-nitro-, Methyl ester(850462-65-6)
• EPA Substance Registry System: Benzoic acid,2-(broMoMethyl)-5-fluoro-3-nitro-, Methyl ester(850462-65-6)

Safety Data

• Hazardous Substances Data: 850462-65-6(Hazardous Substances Data)

Usage

Description

Benzoic acid, 2-(bromoMethyl)-5-fluoro-3-nitro-, Methyl ester, also known as 5-Fluoro-3-nitro-2-(bromomethyl)benzoic acid methyl ester, is a chemical compound with the molecular formula C9H7BrFNO4. It is a methyl ester derivative of 5-fluoro-3-nitrobenzyl bromide and is often used in pharmaceutical and chemical research. Benzoic acid,2-(broMoMethyl)-5-fluoro-3-nitro-, Methyl ester is known for its potential use in the synthesis of various biologically active compounds and may have anti-inflammatory and analgesic properties.

Uses

Used in Pharmaceutical Industry:
Benzoic acid, 2-(bromoMethyl)-5-fluoro-3-nitro-, Methyl ester is used as an intermediate in the synthesis of various biologically active compounds for pharmaceutical applications. Its unique structure allows for the development of new drugs with potential therapeutic benefits.
Used in Chemical Research:
Benzoic acid,2-(broMoMethyl)-5-fluoro-3-nitro-, Methyl ester is also utilized in chemical research for studying the properties and reactions of related chemical entities. It aids in understanding the behavior of similar compounds and contributes to the advancement of chemical knowledge.
It is important to handle Benzoic acid, 2-(bromoMethyl)-5-fluoro-3-nitro-, Methyl ester with caution as it may be harmful if ingested, inhaled, or in contact with the skin, and should be stored and disposed of properly according to safety guidelines.

Upstream product

• 697739-03-0 5-fluoro-2-methyl-3-nitrobenzoic acid methyl ester 
• 33184-16-6 5-fluoro-2-methylbenzoic acid 

Downstream Products

• 850462-66-7 2-(azidomethyl)-5-fluoro-3-nitrobenzoic acid methyl ester 
• 1207453-90-4 6-fluoro-4-nitroisobenzofuran-1(3H)-one 
• 1207453-97-1 8-(4-((dimethylamino)methyl)phenyl)-9-(1-methyl-1H-imidazol-2-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one 
• 1207455-40-0 9-(1-methyl-1H-imidazol-2-yl)-8-(4-(pyrrolidin-1-ylmethyl)phenyl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one 
• 1207453-91-5 4-amino-6-fluoroisobenzofuran-1(3H)-one 
• 1207453-92-6 (E)-4-(benzylideneamino)-6-fluoroisobenzofuran-1(3H)-one 
• 1207453-93-7 ethyl 7-fluoro-3-(1-methyl-1H-imidazol-2-yl)-4-oxo-2-phenyl-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207453-95-9 (E)-6-fluoro-4-(4-fluorobenzylideneamino)isobenzofuran-1(3H)-one 
• 1207453-98-2 ethyl 2-(4-(diethoxymethyl)phenyl)-3-(1-methyl-1H-imidazol-2-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207453-99-3 8-(4-(diethoxymethyl)phenyl)-9-(1-methyl-1H-imidazol-2-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one 
• 1207454-00-9 4-(9-(1-methyl-1H-imidazol-2-yl)-3-oxo-3,7,8,9-tetrahydro-2H-pyrido[4,3,2-de]phthalazin-8-yl)benzaldehyde 
• 1207454-57-6 ethyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207455-88-6 ethyl 7-fluoro-3-(1-methyl-1H-1,2,4-triazol-5-yl)-4-oxo-2-phenyl-1,2,3,4-tetrahydroquinoline-5-carboxylate 
• 1207453-96-0 methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1H-imidazol-2-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate 

Relevant articles and documents

HETEROBIFUNCTIONAL COMPOUNDS WITH IMPROVED SPECIFICITYFOR THE BROMODOMAIN OF BRD4

Disclosed are heterobifunctional compounds that effectuate selective degradation of a target protein, and which include a targeting ligand that binds a target protein and at least one other protein, a ligand that binds an E3 ubiquitin ligase or a component of E3 ubiquitin ligase, and a specificity modulating linker that links the first ligand and the second ligand. Pharmaceutical compositions containing the compounds, and methods of using and making the compounds are also disclosed.

Isoindoline derivative and intermediate, preparation method, pharmaceutical composition and application thereof

The invention discloses an isoindoline derivative, and an intermediate, a preparation method, a pharmaceutical composition and application thereof. The isoindoline derivative of the invention and the pharmaceutical composition thereof can adjust productio

METHODS OF USING DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY (ADP-RIBOSE)POLYMERASE (PARP)

Provided herein are methods of treating cancer comprising administering a topoisomerase inhibitor, temozolomide, or a platin in combination with a Compound of Formula (I) or Formula (II), where the substituents Y, Z, A, B, R1, R2, R3, R4 and R5 are as defined herein.